Defective pulmonary vascular remodeling in Smad8 mutant mice

Human Molecular Genetics

Volumn 18, Issue 15, 2009, Pages 2791-2801

  Huang, Zheng ^a   Wang, Degang ^a   Ihida Stansbury, Kaori ^b   Jones, Peter Lloyd ^b   Martin, James F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; HOMEODOMAIN PROTEIN; SMAD8 PROTEIN; TENASCIN; TRANSCRIPTION FACTOR PRX 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE MUTATION; GENE TARGETING; LUNG ADENOMA; LUNG BLOOD VESSEL; MOUSE; MOUSE MUTANT; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MICE; MICE, KNOCKOUT; MUTATION; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SMAD8 PROTEIN;

MUS;

EID: 67650721435     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp214     Document Type: Article

References (65)

1. Hogan, B.L. (1996) Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes. Dev., 10, 1580-1594.
2. Derynck, R. and Zhang, Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 425, 577-584.
3. Davis, B.N., Hilyard, A.C., Lagna, G. and Hata, A. (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 454, 56-61.
4. Waite, K.A. and Eng, C. (2003) From developmental disorder to heritable cancer: It's all in the BMP/TGF-beta family. Nat. Rev. Genet., 4, 763-773.
5. Eng, C. (2001) To be or not to BMP. Nat. Genet., 28, 105-107.
6. Lane, K.B., Machado, R.D., Pauciulo, M.W., Thomson, J.R., Phillips, J.A., Loyd, J.E., Nichols, W.C. and Trembath, R.C. (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet., 26, 81-84.
7. Farber, H.W. and Loscalzo, J. (2004) Pulmonary arterial hypertension. N. Engl. J. Med., 351, 1655-1665.
8. Deng, Z., Morse, J.H., Slager, S.L., Cuervo, N., Moore, K.J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S.G., Barst, R.J. et al. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am. J. Hum. Genet., 67, 737-744.
9. Morrell, N.W. (2006) Pulmonary hypertension due to BMPR2 mutation: A new paradigm for tissue remodeling? Proc. Am. Thorac. Soc., 3, 680-686.
10. Shintani, M., Yagi, H., Nakayama, T., Saji, T. and Matsuoka, R. (2009) A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. J. Med. Genet, 46, 331-337.
11. Haramis, A.P., Begthel, H., van den Born, M., van Es, J., Jonkheer, S., Offerhaus, G.J. and Clevers, H. (2004) De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science, 303, 1684-1686.
12. Howe, J.R., Bair, J.L., Sayed, M.G., Anderson, M.E., Mitros, F.A., Petersen, G.M., Velculescu, V.E., Traverso, G. and Vogelstein, B. (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet., 28, 184-187.
13. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Cho, T.J., Choi, I.H., Connor, J.M., Delai, P., Glaser, D.L., LeMerrer, M. et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet., 38, 525-527.
14. Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H. and Massague, J. (2007) Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell, 25, 441-454.
15. Liu, W., Selever, J., Wang, D., Lu, M.F., Moses, K.A., Schwartz, R.J. and Martin, J.F. (2004) Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc. Natl Acad. Sci. USA, 101, 4489-4494.
16. Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M.M. and Zwijsen, A. (1999) Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development, 126 1631-1642.
17. Chang, H., Zwijsen, A., Vogel, H., Huylebroeck, D. and Matzuk, M.M. (2000) Smad5 is essential for left-right asymmetry in mice. Dev. Biol., 219, 71-78.
18. Yang, X., Castilla, L.H., Xu, X., Li, C., Gotay, J., Weinstein, M., Liu, P.P. and Deng, C.X. (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development, 126, 1571-1580.
19. Lechleider, R.J., Ryan, J.L., Garrett, L., Eng, C., Deng, C., Wynshaw-Boris, A. and Roberts, A.B. (2001) Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev. Biol., 240, 157-167.
20. Tremblay, K.D., Dunn, N.R. and Robertson, E.J. (2001) Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development, 128, 3609-3621.
21. Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T. and Miyazono, K. (2000) BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev. Biol., 221, 249-258.
22. Mishina, Y., Suzuki, A., Ueno, N. and Behringer, R.R. (1995) Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes. Dev., 9, 3027-3037.
23. Arnold, S.J., Maretto, S., Islam, A., Bikoff, E.K. and Robertson, E.J. (2006) Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev. Biol., 296, 104-118.
24. Orvis, G.D., Jamin, S.P., Kwan, K.M., Mishina, Y., Kaartinen, V.M., Huang, S., Roberts, A.B., Umans, L., Huylebroeck, D., Zwijsen, A. et al. (2008) Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol. Reprod., 78, 994-1001.
25. McCulley, D.J., Kang, J.O., Martin, J.F. and Black, B.L. (2008) BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development. Dev. Dyn., 237, 3200-3209.
26. Ma, L., Lu, M.F., Schwartz, R.J. and Martin, J.F. (2005) Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development, 132, 5601-5611.
27. Jiao, K., Kulessa, H., Tompkins, K., Zhou, Y., Batts, L., Baldwin, H.S. and Hogan, B.L. (2003) An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes. Dev., 17, 2362-2367.
28. Li, Y., Gordon, J., Manley, N.R., Litingtung, Y. and Chiang, C. (2008) Bmp4 is required for tracheal formation: A novel mouse model for tracheal agenesis. Dev. Biol., 322, 145-155.
29. Que, J., Choi, M., Ziel, J.W., Klingensmith, J. and Hogan, B.L. (2006) Morphogenesis of the trachea and esophagus: Current players and new roles for noggin and Bmps. Differentiation, 74, 422-437.
30. Smith, D.M., Nielsen, C., Tabin, C.J. and Roberts, D.J. (2000) Roles of BMP signaling and Nkx2.5 in patterning at the chick midgut-foregut boundary. Development, 127, 3671-3681.
31. Theodosiou, N.A. and Tabin, C.J. (2005) Sox9 and Nkx2.5 determine the pyloric sphincter epithelium under the control of BMP signaling. Dev. Biol., 279, 481-490.
32. Jones, P.L. and Rabinovitch, M. (1996) Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ. Res., 79, 1131-1142.
33. Chapados, R., Abe, K., Ihida-Stansbury, K., McKean, D., Gates, A.T., Kern, M., Merklinger, S., Elliott, J., Plant, A., Shimokawa, H. et al. (2006) ROCK controls matrix synthesis in vascular smooth muscle cells: Coupling vasoconstriction to vascular remodeling. Circ. Res. 99, 837-844.
34. Ihida-Stansbury, K., McKean, D.M., Lane, K.B., Loyd, J.E., Wheeler, L.A., Morrell, N.W. and Jones, P.L. (2006) Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol., 291, L694-L702.
35. Ihida-Stansbury, K., McKean, D.M., Gebb, S.A., Martin, J.F., Stevens, T., Nemenoff, R., Akeson, A., Vaughn, J. and Jones, P.L. (2004) Paired-related homeobox gene prx1 is required for pulmonary vascular development. Circ. Res., 94, 1507-1514.
36. Candia, A.F., Watabe, T., Hawley, S.H., Onichtchouk, D., Zhang, Y., Derynck, R., Niehrs, C. and Cho, K.W. (1997) Cellular interpretation of multiple TGF-beta signals: Intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development, 124, 4467-4480.
37. Furtado, M.B., Solloway, M.J., Jones, V.J., Costa, M.W., Biben, C., Wolstein, O., Preis, J.I., Sparrow, D.B., Saga, Y., Dunwoodie, S.L. et al. (2008) BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Genes. Dev., 22, 3037-3049.
38. Long, L., Crosby, A., Yang, X., Southwood, M., Upton, P.D., Kim, D.K. and Morrell, N.W. (2009) Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: Potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation, 119, 566-576.
39. Morrell, N.W., Yang, X., Upton, P.D., Jourdan, K.B., Morgan, N., Sheares, K.K. and Trembath, R.C. (2001) Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation, 104, 790-795.
40. Phillips, J.A. 3rd, Poling, J.S., Phillips, C.A., Stanton, K.C., Austin, E.D., Cogan, J.D., Wheeler, L., Yu, C., Newman, J.H., Dietz, H.C. et al. (2008) Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet. Med., 10, 359-365.
41. Neptune, E.R., Frischmeyer, P.A., Arking, D.E., Myers, L., Bunton, T.E., Gayraud, B., Ramirez, F., Sakai, L.Y. and Dietz, H.C. (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet., 33, 407-411.
42. Jones, P.L., Crack, J. and Rabinovitch, M. (1997) Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J. Cell. Biol., 139, 279-293.
43. Jones, F.S. and Jones, P.L. (2000) The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn., 218, 235-259.
44. Dettman, R.W. and Steinhorn, R.H. (2004) Connecting the cells: Vascular differentiation via homeobox genes and extracellular matrix in the distal lung [In Process Citation]. Circ. Res., 94, 1406-1407.
45. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science, 277, 48-50.
46. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-248.
47. Cleaver, O. and Melton, D.A. (2003) Endothelial signaling during development. Nat. Med., 9, 661-668.
48. Park, C., Lavine, K., Mishina, Y., Deng, C.X., Ornitz, D.M. and Choi, K. (2006) Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development, 133, 3473-3484.
49. Shang, Y., Yoshida, T., Amendt, B.A., Martin, J.F. and Owens, G.K. (2008) Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J. Cell. Biol., 181, 461-473.
50. Jin, L., Kern, M.J., Otey, C.A., Wamhoff, B.R. and Somlyo, A.V. (2007) Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ. Res., 100, 817-825.
51. Jones, F.S., Meech, R., Edelman, D.B., Oakey, R.J. and Jones, P.L. (2001) Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease. Circ. Res., 89, 131-138.
52. Jiang, F. and Stefanovic, B. (2008) Homeobox gene Prx1 is expressed in activated hepatic stellate cells and transactivates collagen alpha1(I) promoter. Exp. Biol. Med. (Maywood), 233, 286-296.
53. Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P.D., Jeffery, T.K., Atkinson, C., Chen, H., Trembath, R.C. and Morrell, N.W. (2005) Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension [In Process Citation]. Circ. Res., 96, 1053-1063.
54. Foletta, V.C., Lim, M.A., Soosairajah, J., Kelly, A.P., Stanley, E.G., Shannon, M., He, W., Das, S., Massague, J., Bernard, O. et al. (2003) Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol., 162, 1089-1098.
55. Lee-Hoeflich, S.T., Causing, C.G., Podkowa, M., Zhao, X., Wrana, J.L. and Attisano, L. (2004) Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J. 23, 4792-4801.
56. Machado, R.D., Rudarakanchana, N., Atkinson, C., Flanagan, J.A., Harrison, R., Morrell, N.W. and Trembath, R.C. (2003) Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum. Mol. Genet., 12, 3277-3286.
57. West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R. et al. (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ. Res., 94, 1109-1114.
58. West, J., Harral, J., Lane, K., Deng, Y., Ickes, B., Crona, D., Albu, S., Stewart, D. and Fagan, K. (2008) Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am. J. Physiol. Lung Cell Mol. Physiol., 295, L744-L755.
59. Kim, I.Y., Lee, D.H., Lee, D.K., Ahn, H.J., Kim, M.M., Kim, S.J. and Morton, R.A. (2004) Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene, 23 7651-7659.
60. Haudenschild, D.R., Palmer, S.M., Moseley, T.A., You, Z. and Reddi, A.H. (2004) Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer. Cancer Res., 64, 8276-8284.
61. Kim, I.Y., Lee, D.H., Ahn, H.J., Tokunaga, H., Song, W., Devereaux, L.M., Jin, D., Sampath, T.K. and Morton, R.A. (2000) Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res., 60 2840-2844.
62. Lamm, M.L., Podlasek, C.A., Barnett, D.H., Lee, J., Clemens, J.Q., Hebner, C.M. and Bushman, W. (2001) Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev. Biol., 232, 301-314.
63. Horvath, L.G., Henshall, S.M., Kench, J.G., Turner, J.J., Golovsky, D., Brenner, P.C., O'Neill, G.F., Kooner, R., Stricker, P.D., Grygiel, J.J. et al. (2004) Loss of BMP2, Smad8 and Smad4 expression in prostate cancer progression. Prostate, 59, 234-242.
64. He, X.C., Zhang, J., Tong, W.G., Tawfik, O., Ross, J., Scoville, D.H., Tian, Q., Zeng, X., He, X., Wiedemann, L.M. et al. (2004) BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet., 36, 1117-1121.
65. Hester, M., Thompson, J.C., Mills, J., Liu, Y., El-Hodiri, H.M. and Weinstein, M. (2005) Smad1 and smad8 function similarly in Mammalian central nervous system development. Mol. Cell Biol., 25, 4683-4692.